Can an antioxidant slow vision loss? new study tests NAC in retinitis pigmentosa
NCT ID NCT03999021
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 23 times
Summary
This study looks at the long-term safety of an antioxidant called N-Acetylcysteine (NAC) in 30 adults with retinitis pigmentosa, a genetic eye disease that leads to vision loss and blindness. Participants take NAC tablets twice a day for up to 12 months. The goal is to see if NAC is safe and tolerable over time, and to check if it might help preserve vision.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETINITIS PIGMENTOSA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Wilmer Eye Institute at Johns Hopkins University
Baltimore, Maryland, 21287, United States
Conditions
Explore the condition pages connected to this study.